Gelfond Richard L's Form 4 filing
Imax Corp (IMAX) · filed Apr 15, 2026
- Accession no.
- 0001214659-26-004708
- Filed
- Apr 15, 2026
- Trade date
- Apr 13-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.46M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gelfond Richard LCIK 0000944011 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | common shares | CConversionAcquired | +97,462 | $31.40 | +$3,060,306.8 | 862,464 | Direct | |
| Apr 13, 2026 | common shares | SSaleDisposed | −97,462 | $37.15 | −$3,620,713.3 | 765,002 | Direct | |
| Apr 14, 2026 | common shares | CConversionAcquired | +6,924 | $31.40 | +$217,413.6 | 771,926 | Direct | |
| Apr 14, 2026 | common shares | SSaleDisposed | −6,924 | $37.07 | −$256,672.68 | 765,002 | Direct | |
| Apr 15, 2026 | common shares | CConversionAcquired | +15,746 | $31.40 | +$494,424.4 | 780,748 | Direct | |
| Apr 15, 2026 | common shares | SSaleDisposed | −15,746 | $37.07 | −$583,704.22 | 765,002 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | common shares | CConversionDisposed | −97,462 | $31.40 | −$3,060,306.8 | 1,439,943 | Direct | |
| Apr 14, 2026 | common shares | CConversionDisposed | −6,924 | $31.40 | −$217,413.6 | 1,433,019 | Direct | |
| Apr 15, 2026 | common shares | CConversionDisposed | −15,746 | $31.40 | −$494,424.4 | 1,417,273 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.